chitosan has been researched along with Deep Vein Thrombosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drozd, NN; Il'ina, AV; Shagdarova, BT; Varlamov, VP | 1 |
| Jin, HJ; Sun, ML; Zhang, BG; Zhang, H; Zhang, JW | 1 |
| Bagre, AP; Jain, K; Jain, NK | 1 |
| Hallan, SS; Jain, V; Kaur, V; Mishra, N | 1 |
4 other study(ies) available for chitosan and Deep Vein Thrombosis
| Article | Year |
|---|---|
Effect of Oligochitosan on Experimental Venous Thrombosis in Guinea Pigs.
Topics: Animals; Anticoagulants; Chitosan; Chlorophyta; Erythrocytes; Female; Guinea Pigs; Humans; Oligosaccharides; Platelet Aggregation; Venous Thrombosis | 2021 |
Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo.
Topics: Animals; Chitosan; Male; Nanoparticles; Rabbits; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2013 |
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Topics: Administration, Oral; Alginates; Animals; Anticoagulants; Biological Availability; Chitosan; Drug Carriers; Enoxaparin; Glucuronic Acid; Hexuronic Acids; Intestinal Mucosa; Nanoparticles; Rats; Rats, Sprague-Dawley; Venous Thrombosis | 2013 |
Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH.
Topics: Administration, Oral; Amines; Biological Transport; Caco-2 Cells; Chitosan; Drug Carriers; Heparin, Low-Molecular-Weight; Humans; Nanoparticles; Permeability; Venous Thrombosis | 2017 |